Kobayashi Pharmaceutical Co Ltd
TSE:4967

Watchlist Manager
Kobayashi Pharmaceutical Co Ltd Logo
Kobayashi Pharmaceutical Co Ltd
TSE:4967
Watchlist
Price: 5 994 JPY 0.54% Market Closed
Market Cap: 445.6B JPY
Have any thoughts about
Kobayashi Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Kobayashi Pharmaceutical Co Ltd

Current Assets 126.7B
Cash & Short-Term Investments 51.7B
Receivables 39.6B
Other Current Assets 35.5B
Non-Current Assets 123.8B
Long-Term Investments 33.6B
PP&E 65.4B
Intangibles 19.5B
Other Non-Current Assets 5.3B
Current Liabilities 39.6B
Accounts Payable 13.9B
Accrued Liabilities 1.7B
Other Current Liabilities 24.1B
Non-Current Liabilities 6.2B
Long-Term Debt 592m
Other Non-Current Liabilities 5.6B

Balance Sheet
Kobayashi Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
58 173
64 990
74 456
75 580
78 253
95 024
96 233
71 536
Cash Equivalents
58 173
64 990
74 456
75 580
78 253
95 024
96 233
71 536
Short-Term Investments
5 500
8 300
8 300
14 977
16 085
14 022
8 300
8 300
Total Receivables
47 000
49 998
53 255
54 105
52 829
55 147
47 853
52 984
Accounts Receivables
47 000
49 998
53 255
54 105
52 829
55 147
47 853
52 984
Other Receivables
0
0
0
0
0
0
0
0
Inventory
12 805
13 289
13 643
15 325
14 139
15 107
17 678
22 081
Other Current Assets
5 168
5 769
2 170
3 059
2 919
2 589
2 828
3 430
Total Current Assets
128 646
142 346
151 824
163 046
164 225
181 889
172 892
158 331
PP&E Net
17 833
18 247
19 024
21 180
20 821
22 524
34 778
47 665
Intangible Assets
2 494
2 172
1 582
1 530
5 510
5 469
6 160
11 959
Goodwill
4 729
2 626
3 241
1 582
7 284
7 189
7 147
9 655
Note Receivable
171
261
386
572
700
816
975
1 132
Long-Term Investments
43 248
49 778
48 872
42 260
37 239
32 201
31 216
34 802
Other Long-Term Assets
4 113
3 401
3 858
3 562
2 587
2 466
2 659
3 929
Other Assets
4 729
2 626
3 241
1 582
7 284
7 189
7 147
9 655
Total Assets
201 234
N/A
218 831
+9%
228 787
+5%
233 732
+2%
238 366
+2%
252 554
+6%
255 827
+1%
267 473
+5%
Liabilities
Accounts Payable
16 018
17 500
17 776
16 815
15 926
17 444
18 056
17 305
Accrued Liabilities
2 237
3 495
3 542
3 592
4 214
3 125
3 474
3 493
Short-Term Debt
192
194
506
19
13
1
0
0
Current Portion of Long-Term Debt
56
55
53
190
170
169
261
379
Other Current Liabilities
28 472
33 030
33 176
33 151
29 784
29 964
30 018
34 934
Total Current Liabilities
46 975
54 274
55 053
53 767
50 107
50 703
51 809
56 111
Long-Term Debt
581
527
472
682
505
460
531
608
Deferred Income Tax
3 841
5 224
2 812
2 779
1 357
1 564
1 310
2 594
Other Liabilities
6 517
4 995
4 201
3 847
3 814
4 227
4 277
3 344
Total Liabilities
57 914
N/A
65 020
+12%
62 538
-4%
61 075
-2%
55 783
-9%
56 954
+2%
57 927
+2%
62 657
+8%
Equity
Common Stock
3 450
3 450
3 450
3 450
3 450
3 450
3 450
3 450
Retained Earnings
147 968
146 794
159 857
173 650
187 071
200 587
194 545
206 127
Additional Paid In Capital
4 958
4 183
4 183
4 183
4 183
4 183
522
522
Unrealized Security Profit/Loss
9 481
13 267
12 636
13 212
10 449
10 953
10 346
12 819
Treasury Stock
21 088
12 259
11 763
19 762
19 763
23 706
14 482
24 766
Other Equity
1 449
1 624
2 114
2 076
2 807
133
3 519
6 664
Total Equity
143 320
N/A
153 811
+7%
166 249
+8%
172 657
+4%
182 583
+6%
195 600
+7%
197 900
+1%
204 816
+3%
Total Liabilities & Equity
201 234
N/A
218 831
+9%
228 787
+5%
233 732
+2%
238 366
+2%
252 554
+6%
255 827
+1%
267 473
+5%
Shares Outstanding
Common Shares Outstanding
79
82
79
78
78
78
76
74

See Also

Discover More